INTEGRATED BIOPHARMA INC Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Integrated Biopharma Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Integrated Biopharma Inc Entity Common Stock, Shares Outstanding for the quarter ending September 20, 2024 was 30.1M shares, a 0.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 30.1M +150K +0.5% Sep 20, 2024 10-K 2024-09-20
Q1 2024 30.1M +167K +0.56% May 10, 2024 10-Q 2024-05-10
Q4 2023 30.1M +150K +0.5% Feb 12, 2024 10-Q 2024-02-12
Q3 2023 29.9M 0 0% Sep 15, 2023 10-K 2023-09-15
Q1 2023 29.9M 0 0% May 11, 2023 10-Q 2023-05-11
Q4 2022 29.9M +117K +0.39% Feb 10, 2023 10-Q 2023-02-10
Q3 2022 29.9M +129K +0.43% Sep 13, 2022 10-K 2022-09-13
Q1 2022 29.9M +163K +0.55% May 12, 2022 10-Q 2022-05-12
Q4 2021 29.8M +141K +0.48% Feb 10, 2022 10-Q 2022-02-10
Q3 2021 29.8M +174K +0.59% Sep 2, 2021 10-K 2021-09-02
Q1 2021 29.8M +204K +0.69% May 13, 2021 10-Q 2021-05-13
Q4 2020 29.7M +126K +0.43% Feb 12, 2021 10-Q 2021-02-12
Q3 2020 29.6M +80K +0.27% Sep 23, 2020 10-K 2020-09-23
Q1 2020 29.6M 0 0% May 13, 2020 10-Q 2020-05-13
Q4 2019 29.6M 0 0% Feb 12, 2020 10-Q 2020-02-12
Q3 2019 29.6M +200K +0.68% Aug 29, 2019 10-K 2019-08-29
Q1 2019 29.6M +8.43M +39.9% May 15, 2019 10-Q 2019-05-15
Q4 2018 29.6M +8.43M +39.9% Feb 13, 2019 10-Q 2019-02-13
Q3 2018 29.4M +8.23M +38.9% Sep 12, 2018 10-K 2018-09-12
Q1 2018 21.1M +5K +0.02% May 9, 2018 10-Q 2018-05-09
Q4 2017 21.1M +5K +0.02% Feb 9, 2018 10-Q 2018-02-09
Q3 2017 21.1M +30K +0.14% Sep 1, 2017 10-K 2017-09-01
Q1 2017 21.1M +25K +0.12% May 10, 2017 10-Q 2017-05-10
Q4 2016 21.1M +25K +0.12% Feb 10, 2017 10-Q 2017-02-10
Q3 2016 21.1M 0 0% Sep 2, 2016 10-K 2016-09-02
Q1 2016 21.1M 0 0% May 13, 2016 10-Q 2016-05-13
Q4 2015 21.1M Feb 12, 2016 10-Q 2016-02-19
Q3 2015 21.1M 0 0% Sep 4, 2015 10-K 2015-09-04
Q1 2015 21.1M +25K +0.12% Feb 17, 2015 10-Q 2015-02-17
Q3 2014 21.1M +25K +0.12% Sep 8, 2014 10-K 2014-09-08
Q1 2014 21.1M 0 0% May 14, 2014 10-Q 2014-05-14
Q4 2013 21.1M 0 0% Feb 12, 2014 10-Q/A 2014-02-13
Q3 2013 21.1M 0 0% Sep 30, 2013 10-K 2013-09-30
Q1 2013 21.1M +100K +0.48% May 15, 2013 10-Q 2013-05-15
Q4 2012 21.1M +115K +0.55% Feb 14, 2013 10-Q 2013-02-19
Q3 2012 21.1M Oct 13, 2012 10-K 2012-10-15
Q2 2012 21M May 21, 2012 10-Q 2012-05-21
Q1 2012 21M Feb 21, 2012 10-Q 2012-02-21
Q4 2011 21M Nov 15, 2011 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.